IL147900A0 - Ascididemin derivatives and their therapeutic applications - Google Patents

Ascididemin derivatives and their therapeutic applications

Info

Publication number
IL147900A0
IL147900A0 IL14790000A IL14790000A IL147900A0 IL 147900 A0 IL147900 A0 IL 147900A0 IL 14790000 A IL14790000 A IL 14790000A IL 14790000 A IL14790000 A IL 14790000A IL 147900 A0 IL147900 A0 IL 147900A0
Authority
IL
Israel
Prior art keywords
ascididemin
derivatives
therapeutic applications
compounds
antitumoral
Prior art date
Application number
IL14790000A
Other languages
English (en)
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9910490A external-priority patent/FR2797445B1/fr
Priority claimed from FR0006652A external-priority patent/FR2809399B1/fr
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of IL147900A0 publication Critical patent/IL147900A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
IL14790000A 1999-08-13 2000-08-11 Ascididemin derivatives and their therapeutic applications IL147900A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9910490A FR2797445B1 (fr) 1999-08-13 1999-08-13 Derives d'ascididemine et leurs applications therapeutiques
FR0006652A FR2809399B1 (fr) 2000-05-24 2000-05-24 Nouveaux derives d'ascididemine et leurs applications therapeutiques
PCT/FR2000/002312 WO2001012631A2 (fr) 1999-08-13 2000-08-11 Derives d'ascididemine et leurs applications therapeutiques

Publications (1)

Publication Number Publication Date
IL147900A0 true IL147900A0 (en) 2002-08-14

Family

ID=26212422

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14790000A IL147900A0 (en) 1999-08-13 2000-08-11 Ascididemin derivatives and their therapeutic applications

Country Status (20)

Country Link
EP (1) EP1202992B1 (ja)
JP (1) JP2003507381A (ja)
CN (1) CN1195754C (ja)
AT (1) ATE276256T1 (ja)
AU (1) AU779932B2 (ja)
BR (1) BR0013249A (ja)
CA (1) CA2393965A1 (ja)
CZ (1) CZ2002528A3 (ja)
DE (1) DE60013849T2 (ja)
DK (1) DK1202992T3 (ja)
ES (1) ES2228602T3 (ja)
HU (1) HUP0202767A3 (ja)
IL (1) IL147900A0 (ja)
MX (1) MXPA02001512A (ja)
NO (1) NO20020668L (ja)
NZ (1) NZ516896A (ja)
PL (1) PL353453A1 (ja)
PT (1) PT1202992E (ja)
SK (1) SK1662002A3 (ja)
WO (1) WO2001012631A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11466021B2 (en) * 2016-12-05 2022-10-11 Merck Patent Gmbh Materials for organic electroluminescent devices

Also Published As

Publication number Publication date
CZ2002528A3 (cs) 2002-05-15
HUP0202767A2 (hu) 2003-01-28
ES2228602T3 (es) 2005-04-16
NO20020668L (no) 2002-04-15
PT1202992E (pt) 2004-12-31
AU779932B2 (en) 2005-02-17
NZ516896A (en) 2004-02-27
PL353453A1 (en) 2003-11-17
CN1373762A (zh) 2002-10-09
BR0013249A (pt) 2002-04-16
DK1202992T3 (da) 2005-01-24
AU7012400A (en) 2001-03-13
JP2003507381A (ja) 2003-02-25
CN1195754C (zh) 2005-04-06
EP1202992B1 (fr) 2004-09-15
HUP0202767A3 (en) 2003-12-29
SK1662002A3 (en) 2002-09-10
DE60013849D1 (de) 2004-10-21
EP1202992A2 (fr) 2002-05-08
WO2001012631A3 (fr) 2001-07-19
DE60013849T2 (de) 2005-02-03
WO2001012631A2 (fr) 2001-02-22
NO20020668D0 (no) 2002-02-11
ATE276256T1 (de) 2004-10-15
CA2393965A1 (fr) 2001-02-22
MXPA02001512A (es) 2002-07-02

Similar Documents

Publication Publication Date Title
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
GEP20063799B (en) Tropane derivatives useful in therapy
GEP20032896B (en) 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment
ATE312080T1 (de) 2-chinolonen enthaltende arzneimittel
GEP20043241B (en) Compounds for Treatment of Ischemia and Pharmaceutical Compositions Containing the Same
GEP20033001B (en) Alkynyl-Substituted Quinolin-2-One Derivatives Useful As Anticancer Agents
GEP20053454B (en) Aryl Fused Azapolycyclic Compounds, Composition Containing the Same and Use Thereof
GEP20032999B (en) 1-Heterocycle Substituted Diarylamines
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
MY127126A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
BG104412A (en) Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
AP2002002578A0 (en) Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses.
MXPA02012034A (es) Derivados de tiofeno utiles como agentes anticancerosos.
BG103947A (en) Derivatives of 9-oxymerythromycin
GEP20043250B (en) Use of Indolyl-3-Glyoxylic Acid Derivatives as Anti-tumor Means and Pharmaceutical Compositions Containing the Same
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
YU59400A (sh) Azabiciklični ligandi 5ht1 receptora
AP9801377A0 (en) Tricyclic erythromycin derivatives.
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
WO2001012632A3 (fr) Derives de phenanthroline-7-ones et leurs applications en therapeutique
IL147900A0 (en) Ascididemin derivatives and their therapeutic applications
WO2001012607A3 (fr) Compositions pharmaceutiques comprenant des 4-quinolones pour le traitement des cancers